Palo Alto, CA: A significant minority of pediatric patients with cerebral palsy (CP) are using CBD supplements to mitigate disease symptoms, according to survey data published in the journal Orthopedics.
Stanford University researchers surveyed the caregivers of children with CP regarding their use of CBD products.
Seventeen percent of respondents acknowledged that their children consumed CBD. CBD products were most frequently administered to pediatric patients for purposes of alleviating spasticity, anxiety, and pain. The majority of respondents reported that their children experienced no adverse effects from CBD treatment.
“Caregivers perceive CBD as offering some benefits, particularly in the domains of emotional health, spasticity, and pain,” authors concluded. “CBD may serve as a useful adjunct for some children with CP, especially those with worse disease severity.”
Full text of the study, “Cannabidiol use patterns and efficacy for children who have cerebral palsy,” appears in Orthopedics.